For inflammatory macrophage (M1) differentiation, MФ were stimulated with 100 ng/mL LPS and 100 ng/mL recombinant IFN‐γ (R&D Systems, Minneapolis, MN, USA) for 24 hours. To generate anti‐inflammatory macrophages (M2), MФ were stimulated with 100 ng/mL recombinant IL‐4 (R&D Systems), 20ng/mL recombinant IL‐10 (R&D Systems) and 100 ng/mL recombinant IL‐13 (R&D Systems) for 24 hours. Polarized cells were identified by flow cytometry with myeloid and lymphoid immunophenotyping panels. Primary antibodies used in the flow cytometry analysis are as follows: CD11b (BD Biosciences, Franklin Lakes, NJ, USA), CD206 (BD Biosciences) and F4/80 (Thermo Fisher Scientific, Waltham, MA, USA). Data were collected using a BD LSRFortessa analyser and analysed using FlowJo 10.0 software.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.